Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Liz is Science Editor for Cancer Health, POZ, Hep and Real Health. She has been a health journalist and medical editor for more than 20 years, covering HIV, viral hepatitis, cancer and other health issues.
People who received the vaccine did, however, show stronger immune responses against the virus.
Nine grants will enable researchers to study CBD and other components of marijuana.
Judge’s ruling may pave the way for opening the nation’s first supervised overdose prevention facility.
Immunotherapy did not improve overall survival but led to fewer side effects and better quality of life.
Efforts to control viral hepatitis are falling behind, in part because of the growing opioid epidemic and homelessness crisis.
Wider screening would prevent liver cirrhosis, liver cancer and the need for liver transplants.
National survey finds HBV rate is four times higher than that of the overall U.S. population.
FDA warns that drinking Miracle Mineral Solution and similar products is potentially life-threatening.
The presence of less studied HCV genotypes may compromise cure rates.
Large European study finds that more than 1 in 10 people with HIV acquire HCV again.
Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.
National survey finds a majority of people with HBV or HCV don’t know their status.
Study finds people who took daily aspirin had a lower risk of NASH and advanced liver scarring.
CDC experts recommend the vaccine for children, teens and HIV-positive people.
Phase III study misses statistical threshold, but the immunotherapy appears to show some benefit.
Study in China sees an association with several cancer types, especially gastrointestinal malignancies.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.